Synthesis, In vivo , and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202400642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Himanshu Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Noida Institute of Engineering and Technology, Pharmacy Institute), Greater Noida, 201310, India. Hauptthemen laut MEDLINE: Anticonvulsants, Benzothiazoles, Pyrazoles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India.
Abstract (Originalsprache)
New 2‐(4‐benzothiazol‐2‐yl‐phenoxy)‐1‐(3,5‐diphenyl‐4,5‐dihydro‐pyrazol‐1‐yl)‐ethanones (9a–o) have been designed and synthesized. All the synthesized compounds were characterized by thin layer chromatography and spectral analysis. The antiepileptic potential of the synthesized compounds has been tested by following standard animal screening models, including maximal electroshock (MES) and subcutaneous pentylenetetrazole ( sc PTZ) models. The neurotoxic and antidepression effects of the synthesized compounds were checked by utilizing rotarod apparatus, and motor impairment test (by actophotometer) respectively. The study concluded that compounds 9c, 9d, 9f, 9i, 9n , and 9o possessed good antiepileptic potential compared to standard drugs like carbamazepine and phenytoin. The results of the rotarod performance test also established them without any neurotoxicity. The motor impairment test revealed that the synthesized compounds are also good antidepressants. In‐silico studies have been performed for calculation of pharmacophore pattern, prediction of pharmacokinetic properties which determine the eligibility of synthesized compounds as orally administered molecules and interactions with the target proteins. The result of in‐silico studies reinforced results obtained by in vivo study of the synthesized compounds and their possible mechanism of antiepileptic action i. e. via inhibiting voltage‐gated sodium channels (VGSCs) and gamma‐aminobutyric acid‐A receptor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Noida Institute of Engineering and Technology, Pharmacy Institute), Greater Noida, 201310, India.
- School of Pharmacy, Graphic Era Hill University, 248002, Dehradun, India.
- ANA Institute of Pharmaceutical Sciences and Research, Bareilly, 243501, India.
- Department of Biotechnology, Noida Institute of Engineering and Technology, 201310, Greater Noida, India.
- School of Pharmaceutical Science, Lovely Professional University, 144001, Phagwara, India.
ORCID-Profile: Himanshu Singh, Rajnish Kumar, Avijit Mazumder, Salahuddin, Ranjeet Kumar Yadav
Förderung
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India
Zitieren
APA
Singh, H., Kumar, R., Mazumder, A., Salahuddin, Kumar Yadav, R., Kukreti, N., Abdullah, M. M., Kumar Tyagi, P., & Chaitanya, M. (2024). Synthesis, In vivo , and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400642
Vancouver
Singh H, Kumar R, Mazumder A, Salahuddin, Kumar Yadav R, Kukreti N, et al. Synthesis, In vivo , and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400642
BibTeX
@article{Singh2024,
author = {Singh, Himanshu and Kumar, Rajnish and Mazumder, Avijit and Salahuddin and Kumar Yadav, Ranjeet and Kukreti, Neelima and Abdullah, Mohd Mustaqeem and Kumar Tyagi, Pankaj and Chaitanya, Mvnl},
title = {Synthesis, In vivo , and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202400642}
}
EUVIMED